Tag: #Global Trends

On January 5, 2026, AbbVie entered into a licensing option agreement with China-based Zejing Biopharmaceutical to advance the global development... Read more

Deep Intelligent Pharma (DIP), a Singapore-based leader in medical AI, has secured $50 million in Series D funding. The new... Read more

On January 5, 2026, Skye Bioscience Inc. and Halozyme Therapeutics Inc. announced a global non-exclusive collaboration and licensing agreement to... Read more

As of January 5, 2026, Fujifilm Irvine Scientific Inc. has formally changed its legal name to Fujifilm Biosciences Inc. This... Read more

On January 5, 2026, Japanese pharmaceutical firm Daiichi Sankyo unveiled a major investment plan of approximately $1.9 billion (300 billion... Read more

Pharmaceutical giant Sanofi has signed a significant collaboration deal with Earendil Labs, a biotech startup, to leverage bispecific antibody technology... Read more

On January 5, 2026, the Centers for Disease Control and Prevention (CDC) announced a major overhaul of the national childhood... Read more

On January 5, 2026, Sanofi announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the... Read more

Fresh from its successful IPO in Hong Kong, AI-driven biotech Insilico Medicine has kicked off the year by entering an... Read more